Mazdutide Research Compound (MAZ)

"Premium grade Mazdutide validation."

Mazdutide (IBI362) is a synthetic dual GLP-1 and glucagon receptor agonist studied in metabolic pathway research. The GLORY-1 phase 3 clinical program in adults with obesity or overweight reported dose-dependent reductions in body weight with the 4 mg and 6 mg once-weekly doses (Ji et al., N Engl J Med 2025, PMID 40421736). Mazdutide research peptide is supplied lyophilized at ≥99% purity verified by HPLC, with identity confirmed by mass spectrometry and a batch-specific Certificate of Analysis (COA) included. Store lyophilized powder at −20 °C, protected from light and moisture. For laboratory research use only — not for human or animal consumption.